Answers are grounded in this paper and cite their sources.
Despite multiple therapeutic modalities, the overall survival of patients with gastric adenocarcinoma remains poor, especially for advanced tumor stages. Although the tyrosine kinase MerTK has shown therapeutic relevance in several tumor entities, its potential effects in gastric adenocarcinoma have not yet been sufficiently characterized.
No takes yet. Share an insight, caveat, or question.
Wirsik et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: